Genes y Ambiente en Esquizofrenia

Inicio - Portada

quienes somos

Empleo

Formación

publicaciones

quienes somos

Madrid Declaration

contacto

Colaborar - Participar

Lun Mar Mié Jue Vie Sáb Dom
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31

eventos-noticias

Publicaciones AGES-CM

Título

Año

Autores

Revista

       

Working definitions, subjective and objective assessments and experimental paradigms in a study exploring social withdrawal in schizophrenia and Alzheimer's disease

2019

van der Wee, NJA.; Bilderbeck, AC.; Cabello, M.; Ayuso-Mateos, JL.; Saris, IMJ.; Giltay, EJ.; Penninx, BW.; Arango, C.; Post, A.; Porcelli, S.

Neuroscience and Biobehavioral Reviews

       

Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study

2019

Quattrone, D.; Di Forti, M.; Gayer-Anderson, C.; Ferraro, L.; Jongsma, HE.; Tripoli, G et al.

Psychological Medicine

       

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study

2019

Di Forti M, Quattrone D, Freeman TP, Tripoli G, Gayer-Anderson C, Quigley H, Rodriguez V, Jongsma HE, Ferraro L, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Tortelli A, Velthorst E, Bernardo M, Del-Ben CM, Menezes PR, Selten JP, Jones PB, Kirkbride JB, Rutten BP, de Haan L, Sham PC, van Os J, Lewis CM, Lynskey M, Morgan C, Murray RM; EU-GEI WP2 Group.

Lancet Psychiatry

Smoking does not impact social and non-social cognition in patients with first episode psychosis

2019

Sánchez-Gutiérrez, T.; García-Portilla, MP.; Parellada, M.; Bobes, J.; Calvo, A.; Moreno-Izco, L.; González-Pinto, A.; Lobo, A.; de la Serna, E.; Cabrera, B.; Torrent, C.; Roldán, L.; Sanjuan, J.; Ibáñez, Á.; Sánchez-Torres, AM.; Corripio, I.; Bernardo, M.; Cuesta, MJ; PEPs group.

Schizophrenia Research

Re-thinking treatment targets in child and adolescent psychiatry

2019

Moreno C, Zuddas A.

European Child and Adolescent Psychiatry

       

Psychosocial risk factors for suicidality in children and adolescents

2019

Carballo, JJ.; Llorente, C.; Kehrmann, L.; Flamarique, I.; Zuddas, A.; Purper-Ouakil, D.; Hoekstra, PJ.; Coghill, D.; Schulze, UME.; Dittmann, RW.; Buitelaar, JK.; Castro-Fornieles, J.; Lievesley, K.; Santosh, P.; Arango, C; STOP Consortium.

European Child and Adolescent Psychiatry

Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis

2019

Fraguas, D.; Díaz-Caneja, CM.; Ayora, M.; Hernández-Álvarez, F.; Rodríguez-Quiroga, A.; Recio, S.; Leza, JC.; Arango, C.

Schizophrenia Bulletin

       

Overview of the clinical implementation of a study exploring social withdrawal in patients with schizophrenia and Alzheimer's disease

2019

Bilderbeck, AC.; Penninx, BWJH.; Arango, C.; van der Wee, N.; Kahn, R.; Winter-van Rossum, I.; Hayen, A.; Kas, MJ.; Post, A.; Dawson, GR.

Neuroscience and Biobehavioral Reviews

 

 

 

 

Neutrophil Count Is Associated With Reduced Gray Matter and Enlarged Ventricles in First-Episode Psychosis

2019

Núñez, C.; Stephan-Otto, C.; Usall, J.; Bioque, M.; Lobo, A.; González-Pinto, A.; Pina-Camacho, L.; Vieta, E.; Castro-Fornieles, J.; Rodriguez-Jimenez, R.; Butjosa, A.; Janssen, J.; Cabrera, B.; Parellada, M.; Bernardo, M; PEPs group.

Schizophrenia Bulletin

Mobile App-Based Intervention for Adolescents with First-Episode Psychosis: Study Protocol for a Pilot Randomized Controlled Trial

2019

Barbeito, S.; Sánchez-Gutiérrez, T.; Mayoral, M.; Moreno, M.; Ríos-Aguilar, S.; Arango, C.; Calvo, A.

Frontiers in psychiatry

Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain

2019

Arango, C.; Baeza, I.; Bernardo, M.; Cañas, F.; de Dios, C.; Díaz-Marsá, M.; García-Portilla, MP.; Gutiérrez-Rojas, L.; Olivares, JM.; Rico-Villademoros, F.; Rodríguez-Jiménez, R.; Sánchez-Morla, EM.; Segarra, R.; Crespo-Facorro, B.

Revista de Psiquiatría y Salud Mental

Evaluating attention-deficit/hyperactivity disorder using ecological momentary assessment: a systematic review

2019

Miguelez-Fernandez, C.; de Leon, SJ.; Baltasar-Tello, I.; Peñuelas-Calvo, I.; Barrigon, ML.; Capdevila, AS.; Delgado-Gómez, D.; Baca-García, E.; Carballo, JJ.

Attention Deficit and Hyperactivity Disorders

Differences in the regulation of inflammatory pathways in adolescent- and adult-onset first-episode psychosis

2019

Moreno C, Parellada M, MacDowell KS, García-Bueno B, Cabrera B, González-Pinto A, Saiz P, Lobo A, Rodriguez-Jimenez R, Berrocoso E, Bernardo M, Leza JC; From the FLAMM-PEPs study.

European Child and Adolescent Psychiatry

Cognitive reserve as an outcome predictor: first-episode affective versus non-affective psychosis 

2019

Amoretti, S.; Cabrera, B.; Torrent, C.; Mezquida, G.; Lobo, A.; González-Pinto, A.; Parellada, M.; Corripio, I.; Vieta, E.; de la Serna, E.; Butjosa, A.; Contreras, F.; Sarró, S.; Penadés, R.; Sánchez-Torres, AM.; Cuesta, M.; Bernardo, M; PEPsGroup.

Acta Psychiatrica Scandinavica

Cognition and functionality in delusional disorder

2019

Díaz-Caneja, C.; Cervilla, JA.; Haro, JM.; Arango, C.; de Portugal, E.

European Psychiatry

Affective versus first-episode non-affective first-episode psychoses: A longitudinal study

2019

Torrent, C.; Reinares, M.; Martinez-Arán, A.; Cabrera, B.; Amoretti, S.; Corripio, I.; Contreras, F.; Sarró, S.; González-Pinto, A.; Lobo, A.; Cuesta, MJ.; Sánchez-Torres, A.; Bergé, D.; Castro-Fornieles, J.; Moreno, M.; Bernardo, M.; Vieta, E.; PEPS group.

Journal of Affective Disorders

Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables

2019

Sánchez-Moreno, J.; Bonnin, CM.; González-Pinto, A.; Amann, BL.; Solé, B.; Balanzá-Martinez, V.; Arango, C.; Jiménez, E.; Tabarés-Seisdedos, R.; Garcia-Portilla, MP.; Ibáñez, A.; Crespo, JM.; Ayuso-Mateos, JL.; Martinez-Aran, A.; Torrent, C.; Vieta, E.; CIBERSAM Functional Remediation Group.

Acta Psychiatrica Scandinavica

       

Negative symptoms of schizophrenia: new developments and unanswered research questions

2019

Galderisi, S.; Mucci, A.; Buchanan, RW.; Arango, C.

Lancet Psychiatry

       

Preventive strategies for mental health

2019

Arango, C.; M. Díaz-Caneja, C.; McGorry, P.; Rapoport, J.; Sommer, I.; Vorstman, J.; McDaid, D.; Marín, O.; Serrano-Drozdowskyj, E.; Freedman, R.; Carpenter, W.

Lancet Psychiatry

       

The complex association between the antioxidant defense system and clinical status in early psychosis

2019

García, S.; Alberich, S.; Martínez-Cengotitabengoa, M.; Arango, C.; Castro-Fornieles, J.; Parellada, M.; Baeza, I.; Moreno, C.; Micó, JA.; Berrocoso, E.; Graell, M.; Otero, S.; Simal, T.; González-Pinto, A.

PLoS One

Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis

2019

Bioque, M.; García-Portilla, MAP.; García-Rizo, C.; Cabrera, B.; Lobo, A.; González-Pinto, A.; Díaz-Caneja, CM.; Corripio, I.; Vieta, E.; Castro-Fornieles, J.; Bobes, J.; Gutiérrez-Fraile, M.; Rodriguez-Jimenez, R.; Mezquida, G.; Llerena, A.; Saiz-Ruiz, J.; Bernardo, M; PEPs GROUP.

Schizophrenia Research

Attenuated psychotic symptoms in children and adolescent offspring of patients with schizophrenia

2019

Noguera, A.; Castro-Fornieles, J.; Romero, S.; de la Serna, E.; Sugranyes, G.; Sánchez-Gistau, V.; Moreno, D.; Díaz-Caneja, CM.; Merchán-Naranjo, J.; Llorente, C.; Baeza, I.

Schizophrenia Research

Negative Symptoms in Early-Onset Psychosis and Their Association With Antipsychotic Treatment Failure

2019

Downs, J.; Dean, H.; Lechler, S.; Sears, N.; Patel, R.; Shetty, H.; Hotopf, M.; Ford, T.; Kyriakopoulos, M.; Diaz-Caneja, CM.; Arango, C.; MacCabe, JH.; Hayes, RD.; Pina-Camacho, L.

Schizophrenia Bulletin.

Predictors of Placebo Response in Pharmacological Clinical Trials of Negative Symptoms in Schizophrenia: A Meta-regression Analysis

2019

Fraguas, D.; Díaz-Caneja, CM.; Pina-Camacho, L.; Umbricht, D.; Arango C.

Schizophrenia Bulletin.

       

A quantitative approach to neuropsychiatry: the why and the how

2019

Kas, MJ.; Penninx, B.; Sommer, B.; Serretti, A.; Arango, C.; Marston H.

Neuroscience & Biobehavioral Reviews

       

 

 

 

Use of Ecological Momentary Assessment (EMA) in Non-Suicidal Self-Injury (NSSI) A systematic review

2018

Rodríguez-Blanco, L.; Carballo, JJ.; Baca-García, E

Psychiatry Research

       

Understanding the pediatric psychiatric phenotype of 22q11. 2 deletion síndrome

2018

Fiksinski, AM.; Schneider, M.; Murphy, CM.; Armando, M.; Vicari, S.; Canyelles, JM.; Gothelf, D.; Eliez, S.; Breetvelt, EJ.; Arango, C.; Vorstman, JAS.

American Journal of Medical Genetics Part A

       

Towards understanding and acting on risk factors for developmental psychopathology

2018

Moreno, C.

European Child and Adolescent Psychiatry

       
       

The Strengths and Difficulties Questionnaire -Dysregulation Profile, Non-Suicidal Self-Injury Behaviors and the Mediating Role of Stressful Life Events

2018

Caro-Cañizares, I.; Díaz de Neira-Hernando, M.; Pfang, B.; Baca-Garcia, E.; Carballo, JJ.

Spanish Journal of Psychology

       

The need for paediatric registries to assess long-term brain effects of psychotropic medications: The case of bipolar disorder

2018

Vieta, E.; Arango, C.; Rush, AJ.

European Neuropsychopharmacology

The complex association between the antioxidant defense system and clinical status in early psychosis

2018

García, S.; Alberich, S.; Martínez-Cengotitabengoa, M.; Arango, C.; Castro-Fornieles, J.; Parellada, M.; Baeza, I.; Moreno, C.; Micó, JA.; Berrocoso, E.; Graell, M.; Otero, S.; Simal, T.; González-Pinto, A.

PLoS One

Temperament in child and adolescent offspring of patients with schizophrenia and bipolar disorder

2018

Díaz-Caneja, CM.; Morón-Nozaleda, MG.; Vicente-Moreno, RP.; Rodríguez-Toscano, E.; Pina-Camacho, L.; de la Serna, E.; Sugranyes, G.; Baeza, I.; Romero, S.; Sánchez-Gistau, V.; Castro-Fornieles, J.; Moreno, C.; Moreno, D.

European Child and Adolescent Psychiatry

Stress hormones and verbal memory in young people over the first 12 weeks of treatment for psychosis

2018

Allott, KA.; Yuen, HP.; Bartholomeusz, CF.; Rapado-Castro, M.; Phassouliotis, C.; Butselaar, F.; Wood, SJ.; Proffitt, TM.; Savage, G.; Phillips, LJ.; Bendall, S.; Markulev, C.; Reniers, RLEP.; Pantelis, C.; Baldwin, L.; McGorry, PD.; Garner, B.

Psychiatry Research

Screening for the ADHD Phenotype Using the Strengths and Difficulties Questionnaire in a Clinical Sample of Newly Referred Children and Adolescents

2018

Carballo, JJ.; Rodríguez-Blanco, L.; García-Nieto, R.; Baca-García, E.

Journal of Attention Disorders

Preventive strategies for mental health

2018

Arango, C.; M. Díaz-Caneja, C.; McGorry, P.; Rapoport, J.; Sommer, I.; Vorstman, J.; McDaid, D.; Marín, O.; Serrano-Drozdowskyj, E.; Freedman, R.; Carpenter, W.

Lancet Psychiatry

Platform for systems medicine research and diagnostic applications in psychotic disorders-The METSY project

2018

Frank, E.; Maier, D.; Pajula, J.; Suvitaival, T.; Borgan, F.; Butz-Ostendorf, M.; Fischer, A.; Hietala, J.; Howes, O.; Hyötyläinen, T.; Janssen, J.; Laurikainen, H.; Moreno, C.; Suvisaari, J.; Van Gils, M.; Orešič, M.

European Psychiatry

One-Year Prospective Study of Liver Function Tests in Children and Adolescents on Second-Generation Antipsychotic

2018

Baeza, I.; Serna, E.; Calvo-Escalona, R.; Merchán-Naranjo, J.; Rodríguez-Latorre, P.; Martínez-Cantarero, MC.; Andrés, P.; Alda, JA.; Muñoz-Samons, D.; Ilzarbe, D.; Arango, C.; Castro-Fornieles, J.

Journal of Child and Adolescent Psychopharmacology

Negative symptoms of schizophrenia: new developments and unanswered research questions

2018

Galderisi, S.; Mucci, A.; Buchanan, RW.; Arango, C.

Lancet Psychiatry

Momentary Assessment and Mood Disorders in Children and Adolescents: a Systematic Review

2018

Baltasar-Tello, I.; Miguélez-Fernández, C.; Peñuelas-Calvo, I.; Carballo, JJ.

Current Psychiatry Reports

Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis

2018

Ballesteros, A.; Sánchez-Torres, AM.; López-Ilundain, JM.; Cabrera, B.; Lobo, A.; González-Pinto, AM.; Díaz-Caneja, C.; Corripio, I.; Vieta, E.; de la Serna, E.; Bobes, J.; Usall, J.; Contreras, F.; Lorente-Omeñaca, R.; Mezquida, G.;

Psychological Medicine

Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis

2018

Gassó, P.; Mas, S.; Bioque, M.; Cabrera, B.; Lobo, A.; González-Pinto, A.; Díaz-Caneja, CM.; Corripio, I.; Vieta, E.; Castro-Fornieles, J.; Sarró, S.; Mané, A.; Sanjuan, J.; Llerena, A.; Lafuente, A.; Saiz-Ruiz, J.; Bernardo, M; PEPs Group.

Journal of Psychopharmacology

Factors associated with poor functional outcome in bipolar disorder sociodemographic, clinical, and neurocognitive variables

2018

Sánchez-Moreno, J.; Bonnin, CM.; González-Pinto, A.; Amann, BL.; Solé, B.; Balanzá-Martinez, V.; Arango, C.; Jiménez, E.; Tabarés-Seisdedos, R.; Garcia-Portilla, MP.; Ibáñez, A.; Crespo, JM.; Ayuso-Mateos, JL.; Martinez-Aran, A.; Torrent, C.; Vieta, E.; CIBERSAM Functional Remediation Group.

Acta Psychiatrica Scandinavica

Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis

2018

Bioque, M.; García-Portilla, MAP.; García-Rizo, C.; Cabrera, B.; Lobo, A.; González-Pinto, A.; Díaz-Caneja, CM.; Corripio, I.; Vieta, E.; Castro-Fornieles, J.; Bobes, J.; Gutiérrez-Fraile, M.; Rodriguez-Jimenez, R.; Mezquida, G.; Llerena, A.; Saiz-Ruiz, J.; Bernardo, M; PEPs GROUP.

Schizophrenia Research

       

Cardiovascular Risk in Early Psychosis: Relationship with Inflammation and Clinical Features 6 Months after Diagnosis

2018

Barcones, MF.; MacDowell, KS.; García-Bueno, B.; Bioque, M.; Gutiérrez-Galve, L.; González-Pinto, A.; Parellada, MJ.; Bobes, J.; Bernardo, M.; Lobo, A.; Leza, JC.

International Journal of Neuropsychopharmacology

       

Attenuated psychotic symptoms in children and adolescent offspring of patients with schizophrenia

2018

Noguera, A.; Castro-Fornieles, J.; Romero, S.; de la Serna, E.; Sugranyes, G.; Sánchez-Gistau, V.; Moreno, D.; Díaz-Caneja, CM.; Merchán-Naranjo, J.; Llorente, C.; Baeza, I.

Schizophrenia Research

       

Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

2018

Kahn, RS.; Winter van Rossum, I.; Leucht, S.; McGuire, P.; Lewis, SW.; Leboyer, M.; Arango, C.; Dazzan, P.; Drake, R.; Heres, S.; Díaz-Caneja, CM.; Rujescu, D.; Weiser, M.; Galderisi, S.; Glenthøj, B.; Eijkemans, MJC.; Fleischhacker, WW.; Kapur, S.; Sommer, IE; OPTiMiSE study group.

Lancet Psychiatry

Alpha7 acetylcholine receptor autoantibodies are rare in sera of patients diagnosed with schizophrenia or bipolar disorder

2018

Hoffmann, C.; Stevens, J.; Zong, S.; van Kruining, D.; Saxena, A.; Küçükali, Cİ.; Tüzün, E.; Yalçınkaya, N.; De Hert, M.; González-Vioque, E.; Arango, C.; Lindstrom, J.; De Baets, MH.; Rutten, BPF.; van Os, J.; Molenaar, P.; Losen, M.; Martinez-Martinez, P.

Plos One

Affective versus first-episode non-affective first-episode psychoses: A longitudinal study       

2018

Torrent, C.; Reinares, M.; Martinez-Arán, A.; Cabrera, B.; Amoretti, S.; Corripio, I.; Contreras, F.; Sarró, S.; González-Pinto, A.; Lobo, A.; Cuesta, MJ.; Sánchez-Torres, A.; Bergé, D.; Castro-Fornieles, J.; Moreno, M.; Bernardo, M.; Vieta, E.; PEPS group.

Journal of Affective Disorders

Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables             

2018

Sánchez-Moreno, J.; Bonnin, CM.; González-Pinto, A.; Amann, BL.; Solé, B.; Balanzá-Martinez, V.; Arango, C.; Jiménez, E.; Tabarés-Seisdedos, R.; Garcia-Portilla, MP.; Ibáñez, A.; Crespo, JM.; Ayuso-Mateos, JL.; Martinez-Aran, A.; Torrent, C.; Vieta, E.; CIBERSAM Functional Remediation Group.

Acta Psychiatrica Scandinavica

       

Negative symptoms of schizophrenia: new developments and unanswered research questions

2018

Galderisi, S.; Mucci, A.; Buchanan, RW.; Arango, C.

Lancet Psychiatry

            

     

Preventive strategies for mental health  

2018

Arango, C.; M. Díaz-Caneja, C.; McGorry, P.; Rapoport, J.; Sommer, I.; Vorstman, J.; McDaid, D.; Marín, O.; Serrano-Drozdowskyj, E.; Freedman, R.; Carpenter, W.

Lancet Psychiatry

The complex association between the antioxidant defense system and clinical status in early psychosis             

2018

García, S.; Alberich, S.; Martínez-Cengotitabengoa, M.; Arango, C.; Castro-Fornieles, J.; Parellada, M.; Baeza, I.; Moreno, C.; Micó, JA.; Berrocoso, E.; Graell, M.; Otero, S.; Simal, T.; González-Pinto, A.

PLoS One

Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis      

2018

Bioque, M.; García-Portilla, MAP.; García-Rizo, C.; Cabrera, B.; Lobo, A.; González-Pinto, A.; Díaz-Caneja, CM.; Corripio, I.; Vieta, E.; Castro-Fornieles, J.; Bobes, J.; Gutiérrez-Fraile, M.; Rodriguez-Jimenez, R.; Mezquida, G.; Llerena, A.; Saiz-Ruiz, J.; Bernardo, M; PEPs GROUP.

Schizophrenia Research

Attenuated psychotic symptoms in children and adolescent offspring of patients with schizophrenia  

2018

Noguera, A.; Castro-Fornieles, J.; Romero, S.; de la Serna, E.; Sugranyes, G.; Sánchez-Gistau, V.; Moreno, D.; Díaz-Caneja, CM.; Merchán-Naranjo, J.; Llorente, C.; Baeza, I.

Schizophrenia Research

       

Negative Symptoms in Early-Onset Psychosis and Their Association With Antipsychotic Treatment Failure        

2018

Downs, J.; Dean, H.; Lechler, S.; Sears, N.; Patel, R.; Shetty, H.; Hotopf, M.; Ford, T.; Kyriakopoulos, M.; Diaz-Caneja, CM.; Arango, C.; MacCabe, JH.; Hayes, RD.; Pina-Camacho, L.

Schizophrenia Bulletin.

       

Predictors of Placebo Response in Pharmacological Clinical Trials of Negative Symptoms in Schizophrenia: A Meta-regression Analysis    

2018

Fraguas, D.; Díaz-Caneja, CM.; Pina-Camacho, L.; Umbricht, D.; Arango C.

Schizophrenia Bulletin.

       

A quantitative approach to neuropsychiatry: the why and the how       

2017

Kas, MJ.; Penninx, B.; Sommer, B.; Serretti, A.; Arango, C.; Marston H.

Neuroscience & Biobehavioral Reviews

       

Duration of untreated psychosis and neurocognitive functioning in first-episode psychosis: a systematic review and meta-analysis       

2017

Allott, K.; Fraguas, D.; Bartholomeusz, CF.; Díaz-Caneja, CM.; Wannan, C.; Parrish, EM.; Amminger, GP.; Pantelis, C.; Arango, C.; McGorry, PD.; Rapado-Castro, M.

Psychological Medicine

       

Personality organization and its association with clinical and functional features in borderline personality disorder        

2017

Esguevillas Á, Díaz-Caneja CM, Arango C, Rey-Mejías ÁLD, Bernardo EG, Delgado C, Clarkin JF, Carrasco JL.

Psychiatry Research

       

Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group          

2017

Kelly, S.; Jahanshad, N.; et al.

Molecular Psychiatry

       

Early Intervention in Psychosis: From Clinical Intervention to Health System Implementation  

2017

Csillag, C.; Norentoft, M.; Mizuno, M.; McDaid, D.; Arango, C.; Smith, Jo; Lora, A.; Verma, S.; di Fiandra, T.; Jones, P.B.

Early Intervention in Psychiatry

       

A Psychopathological Comparison between Delusional Disorder and Schizophrenia      

2017

Muñoz-Negro, JE.; Ibáñez-Casas, I.; de Portugal, E.; Lozano-Gutiérrez, V.; Martínez-Leal, R.; Cervilla, JA.

Canadian Journal of Psychiatry

       

Science and fashion: inflammation and oxidative stress in psychiatry    

2017

Arango, C.

European Archives of Psychiatry and Clinical Neuroscience

       

Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study      

2017

Jongsma, HE.; Gayer-Anderson, C.; Lasalvia, A.; Quattrone, D.; Mulè, A.; Szöke, A.; Selten, JP.; Turner, C.; Arango, C.; Tarricone, I.; Berardi, D.; Tortelli, A.; Llorca, PM.; de Haan, L.; Bobes, J.; Bernardo, M.; Sanjuán, J.; Santos, JL.; Arrojo, M.; Del-Ben, CM.; Menezes, PR.; Murray, RM.; Rutten, BP.; Jones, PB.; van Os, J.; Morgan, C.; Kirkbride, JB; European Network of National Schizophrenia Networks Studying Gene-Environment Interactions Work Package 2 (EU-GEI WP2) Group.

JAMA Psychiatry

Gray matter changes and cognitive predictors of 2-year follow-up abnormalities in early-onset first-episode psychosis

2017

Castro-Fornieles, J.; Bargalló, N.; Calvo, A.; Arango, C.; Baeza, I.; Gonzalez-Pinto, A.; Parellada, M.; Graell, M.; Moreno, C.; Otero, S.; Janssen, J.; Rapado-Castro, M.; de la Serna, E.

European Child and Adolescent Psychiatry

       

Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: an umbrella review of meta-analyses    

2017

Belbasis, L.; Köhler, CA.; Stefanis, N.; Stubbs, B.; van Os, J.; Vieta, E.; Seeman, MV.; Arango, C.; Carvalho, AF.; Evangelou, E..

Acta Psychiatrica Scandinavica

       

Effects of functional remediation on neurocognitively impaired bipolar patients: enhancement of verbal memory

2016

Bonnin, CM.; Reinares, M.; Martínez-Arán, A.; Balanzá-Martínez, V.; Sole, B.; Torrent, C.; Tabarés-Seisdedos, R.; García-Portilla, MP.; Ibáñez, A.; Amann, BL.; Arango, C.; Ayuso-Mateos, JL.; Crespo, JM.; González-Pinto, A.; Colom, F.; Vieta, E; CIBERSAM F.

Psychological Medicine

BDNF and NGF Signalling in Early Phases of Psychosis: Relationship With Inflammation and Response to Antipsychotics After 1 Year   

2016

Martinez-Cengotitabengoa, M.; MacDowell, KS.; Alberich, S.; Diaz, FJ.; Garcia-Bueno, B.; Rodriguez-Jimenez, R.; Bioque, M.; Berrocoso, E.; Parellada, M.; Lobo, A.; Saiz, PA.; Matute, C.; Bernardo, M.; Gonzalez-Pinto, A.; Leza, JC; FLAMM-PEPs.

Schizophrenia Bulletin

Neuropsychological characteristics of child and adolescent offspring of patients with bipolar disorder

2016

de la Serna, E.; Vila, M.; Sanchez-Gistau, V.; Moreno, D.; Romero, S.; Sugranyes, G.; Baeza, I.; Llorente, C.; Rodriguez-Toscano, E.; Sánchez-Gutierrez, T.; Castro-Fornieles, J.                Progress in

Neuropsychopharmacology & Biological Psychiatry

Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome

2016

Bonnin, CM.; Torrent, C.; Arango, C.; Amann, BL.; Solé, B.; González-Pinto, A.; Crespo, JM.; Tabarés-Seisdedos, R.; Reinares, M.; Ayuso-Mateos, JL.; García-Portilla, MP.; Ibañez, Á.; Salamero, M.; Vieta, E.; Martinez-Aran, A; CIBERSAM Functional Remediation Group

British Journal of Psychiatry

Executive function is affected in autism spectrum disorder, but does not correlate with intelligence    

2016

Merchán-Naranjo, J.; Boada, L.; Del Rey-Mejías, Á.; Mayoral, M.; Llorente, C.; Arango, C.; Parellada, M.

Revista de Psiquiatría y Salud Mental

       

Cognitive reserve in bipolar disorder: relation to cognition, psychosocial functioning and quality of life               

2016

Anaya, C.; Torrent, C.; Caballero, FF.; Vieta, E.; Bonnin, CD.; Ayuso-Mateos, JL; CIBERSAM Functional Remediation Group

Acta Psychiatrica Scandinavica

       

Building up careers: education and training in translational neuroscience and mental health research  

2015

Rapado-Castro, M.; Pazos, A.; Fañanás, L.; Bernardo, M.; Ayuso-Mateos, JL.; Leza, JC.; Berrocoso, E.; Arriba-Enriquez, J.; Roldán, L.; Sanjuán, J.; Pérez, V.; Haro, JM.; Palomo, T.; Valdizan, E.; Micó, JA.; Sánchez, M.; Arango, C.

Revista de Psiquiatría y Salud Mental

Towards stage specific treatments: Effects of duration of illness on therapeutic response to adjunctive treatment with N-acetyl cysteine in schizophrenia.

2015

Rapado-Castro, M.; Berk, M.; Venugopal, K.; Bush, A.; Dodd, S.; Dean, O.

Progress in Neuropsychopharmacology & Biological Psychiatry

       

Progressive brain changes in children and adolescents with early-onset psychosis: A meta-analysis of longitudinal MRI studies

2015

Fraguas, D.; Díaz-Caneja, CM.; Pina-Camacho, L.; Janssen, J.; Arango, C

Schizophrenia Research

       

Gender effects on brain changes in early-onset psychosis         

2015

Rapado-Castro, M.; Bartholomeusz, CF.; Castro-Fornieles, J.; González-Pinto, A.; Otero, S.; Baeza, I.; Moreno, C.; Graell, M.; Janssen, J.; Bargalló, N.; Pantelis, C.; Desco, M.; Arango, C

European Child and           Adolescent Psychiatry

Cognitive Decline Preceding the Onset of Psychosis in Patients with 22q11.2 Deletion Syndrome      

2015

Vorstman, JA.; Breetvelt, EJ.; Duijff, SN.; Eliez, S.; Schneider, M.; Jalbrzikowski, M.; Armando, M.; Vicari, S.; Shashi, V.; Hooper, SR.; Chow, EW.; Fung, WL.; Butcher, NJ.; Young, DA.; McDonald-McGinn, DM.; Vogels, A.; van, Amelsvoort, T.; Gothelf, D.; Weinberger, R.; Weizman, A.; Klaassen, PW.; Koops, S.; Kates, WR.; Antshel, KM.; Simon, TJ.; Ousley, OY.; Swillen, A.; Gur, RE.; Bearden, CE.; Kahn, RS.; Bassett, AS.; for the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome

JAMA Psychiatry

Functional deterioration from the premorbid period to 2 years after the first episode of psychosis in early-onset psychosis

2015

Del Rey-Mejías, Á.; Fraguas, D.; Díaz-Caneja, CM.; Pina-Camacho, L.; Castro-Fornieles, J.; Baeza, I.; Espliego, A.; Merchán-Naranjo, J.; González-Pinto, A.; de, la, Serna, E.; Payá, B.; Graell, M.; Arango, C.; Parellada, M.

European Child and            Adolescent Psychiatry

Magnetic Resonance Imaging and the Prediction of Outcome in First-Episode Schizophrenia: A Review of Current Evidence and Directions for Future Research        2015      

2015

Dazzan, P.; Arango, C.; Fleischacker, W.; Galderisi, S.; Glenthøj, B.; Leucht, S.; Meyer-Lindenberg, A.; Kahn, R.; Rujescu, D.; Sommer, I.; Winter, I.; McGuire, P.

Schizophrenia Bulletin

       

Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study.

2015

Cuesta, MJ.; Sánchez-Torres, AM.; Cabrera, B.; Bioque, M.; Merchán-Naranjo, J.; Corripio, I.; González-Pinto, A.; Lobo, A.; Bombín, I.; de la Serna, E.; Sanjuan, J.; Parellada, M.; Saiz-Ruiz, J.; Bernardo, M.

Schizophrenia Research

The Promise of Biological Markers for Treatment Response in First-Episode Psychosis: A Systematic Review

2015

Fond, G.; d'Albis, MA.; Jamain, S.; Tamouza, R.; Arango, C.; Fleischhacker, WW.; Glenthøj, B.; Leweke, M.; Lewis, S.; McGuire, P.; Meyer-Lindenberg, A.; Sommer, IE.; Winter-van, Rossum, I.; Kapur, S.; Kahn, RS.; Rujescu, D.; Leboyer, M.

Schizophrenia Bulletin

The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for its Methodology and a Review of the Effectiveness of Switching Antipsychotics   

2015

Leucht, S.; Winter-van Rossum, I.; Heres, S.; Arango, C.; Fleischhacker, WW.; Glenthøj, B.; Leboyer, M.; Leweke, FM.; Lewis, S.; McGuire, P.; Meyer-Lindenberg, A.; Rujescu, D.; Kapur, S.; Kahn, RS.; Sommer, IE.

Schizophrenia Bulletin

       

Modeling Determinants of Medication Attitudes and Poor Adherence in Early Nonaffective Psychosis: Implications for Intervention      

2015

Drake, RJ.; Nordentoft, M.; Haddock, G.; Arango, C.; Fleischhacker, WW.; Glenthøj, B.; Leboyer, M.; Leucht, S.; Leweke, M.; McGuire, P.; Meyer-Lindenberg, A.; Rujescu, D.; Sommer, IE.; Kahn, RS.; Lewis, SW.

Schizophrenia Bulletin

Predictors of outcome in early-onset psychosis: a systematic review    

2015

Díaz-Caneja, C.; Pina-Camacho, L.; Rodríguez-Quiroga, A.; Fraguas, D.; Parellada, M.; Arango, C.

NPJ Schizophrenia

       

The impact of neuropsychological functioning and coping style on perceived stress in individuals with first-episode psychosis and healthy controls

2015

Allott, KA.; Rapado-Castro, M.; Proffitt, TM.; Bendall, S.; Garner, B.; Butselaar, F.; Markulev, C.; Phassouliotis, C.; McGorry, PD.; Wood, SJ.; Cotton, SM.; Phillips, LJ.

Psychiatry Research

       

Bipolar I and II versus unipolar depression: Clinical differences and impulsivity/aggression traits

2015

Dervic, K.; Garcia-Amador, M.; Sudol, K.; Freed, P.; Brent, D.; Mann, JJ.; Harkavy-Friedman, JM.; Oquendo, MA.

European Psychiatry

       

Functional remediation for patients with bipolar II disorder: Improvement of functioning and subsyndromal symptoms

2015

Solé B, Bonnin CM, Mayoral M, Amann BL, Torres I, González-Pinto A, Jimenez E, Crespo JM, Colom F, Tabarés-Seisdedos R, Reinares M, Ayuso-Mateos JL, Soria S, Garcia-Portilla MP, Ibañez A, Vieta E, Martinez-Aran A, Torrent C; the CIBERSAM Functional Remediation Group.

European Neuropsychopharmacology

       

Predictors of schizophrenia spectrum disorders in early-onset first episodes of psychosis: a support vector machine model

2015

Pina-Camacho L, Garcia-Prieto J, Parellada M, Castro-Fornieles J, Gonzalez-Pinto AM, Bombin I, Graell M, Paya B, Rapado-Castro M, Janssen J, Baeza I, Pozo FD, Desco M, Arango C.

European Child and Adolescent Psychiatry

       

Present and future of developmental neuropsychopharmacology     

2015

Arango C

European Neuropsychopharmacology

       

The affective dimension of early-onset psychosis and its relationship with suicide          

2015

Sanchez-Gistau V, Baeza I, Arango C, González-Pinto A, de la Serna E, Parellada M, Graell M, Paya B, Llorente C, Castro-Fornieles J.

Journal of Child Psychology and Psychiatry

       

Tobacco Use in Bipolar Disorder

2015

Thomson, D.; Berk, M.; Dodd, S.; Rapado-Castro, M.; Quirk, SE.; Ellegaard, PK.; Berk, L.; Dean   Clinical

Psychopharmacology and Neuroscience

       

Going Beyond "trial-and-error" in Psychiatric Treatments: OPTiMiSE-ing the Treatment of First Episode of Schizophrenia   

2015

Arango, C.; Kapur, S.; Kahn, RS

Schizophrenia Bulletin

       

Inflammation in schizophrenia: A question of balance             

2015

Leza, JC.; Bueno, B.; Bioque, M.; Arango, C.; Parellada, M.; Do, K.; O'Donnell, P.; Bernardo M

Neuroscience and Biobehavioral Reviews

       

Sources of clinical distress in young people at ultra high risk of psychosis

2015

Rapado-Castro, M.; McGorry, P.; Yung, A.; Calvo, A.; Nelson, B.

Schizophrenia Research

       

Effects of N-Acetyl cysteine on suicidal ideation in bipolar depression                

2015

Waterdrinker, A.; Berk, M.; Venugopal, K.; Rapado-Castro, M.; Turner, A.; Dean, OM.

Journal of Clinical Psychiatry

       

BDNF and NGF Signalling in Early Phases of Psychosis: Relationship With Inflammation and Response to Antipsychotics After 1 Year                

2015

Martinez-Cengotitabengoa, M.; MacDowell, KS.; Alberich, S.; Diaz, FJ.; Garcia-Bueno, B.; Rodriguez-Jimenez, R.; Bioque, M.; Berrocoso, E.; Parellada, M.; Lobo, A.; Saiz, PA.; Matute, C.; Bernardo, M.; Gonzalez-Pinto, A.; Leza, JC; FLAMM-PEPs.

Schizophrenia Bulletin

       

A integral treatment for attention deficit hyperactivity disorder in Europe         

2015

Arango, C

Revista de Psiquiatría y Salud Mental

       

More Treatment for Those Most in Need? A Foregone Conclusion?

2015

Arango C, Kahn RS.

Schizophrenia Bulletin

       

Reduced Gyrification Is Related to Reduced Interhemispheric Connctivity in Autism Spectrum Disorders

2015

Bos, DJ.; Merchán-Naranjo, J.; Martínez, K.; Pina-Camacho, L.; Balsa, I.; Boada, L.; Schnack, H.; Oranje, B.; Desco, M.; Arango, C.; Parellada, M.; Durston, S.; Janssen, J.

Journal of the American Academy of Child and Adolescent Psychiatry

       

Gray Matter Volume Decrease Distinguishes Schizophrenia From Bipolar Offspring During Childhood and Adolescence

2015

Sugranyes, G.; de la Serna, E.; Romero, S.; Sanchez-Gistau, V.; Calvo, A.; Moreno, D.; Baeza, I.; Diaz-Caneja, CM.; Sanchez-Gutierrez, T.; Janssen, J.; Bargallo, N.; Castro-Fornieles, J.

Journal of the American Academy of Child and Adolescent Psychiatry

       

Maternal depression symptoms, unhealthy diet and child emotional-behavioural dysregulation

2015

Pina-Camacho, L.; Jensen, SK.; Gaysina, D.; Barker, ED.

Psychological Medicine

       

Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives

2015

Persico, AM.; Arango, C.; Buitelaar, JK.; Correll, CU.; Glennon, JC.; Hoekstra, PJ.; Moreno, C.; Vitiello, B.; Vorstman, J.; Zuddas, A; European Child and Adolescent Clinical Psychopharmacology Network.

European Neuropsychopharmacology.

       

Psychiatric disorders in child and adolescent offspring of patients with schizophrenia and bipolar disorder: A controlled study

2015

Sanchez-Gistau, V.; Romero, S.; Moreno, D.; de la Serna, E.; Baeza, I.; Sugranyes, G.; Moreno, C.; Sanchez-Gutierrez, T.; Rodriguez-Toscano, E.; Castro-Fornieles, J.

Schizophrenia Research

       

First-Episode Psychosis Research: Time to Move Forward (by Looking Backwards)

2015

Arango, C.

Schizophrenia Bulletin

       

Neuropsychological characteristics of child and adolescent offspring of patients with bipolar disorder

2015

de la Serna, E.; Vila, M.; Sanchez-Gistau, V.; Moreno, D.; Romero, S.; Sugranyes, G.; Baeza, I.; Llorente, C.; Rodriguez-Toscano, E.; Sánchez-Gutierrez, T.; Castro-Fornieles, J.

Progress in Neuropsychopharmacology & Biological Psychiatry

       

Age at first episode modulates diagnosis-related structural brain abnormalities in psychosis

2015

Pina-Camacho, L.; Rey-Mejías, A. Del; Janssen, J.; Bioque, M.; González-Pinto, A.; Arango, C.; Lobo, A.; Sarró, A.; Desco, M.; Sanjuan, J.; Lacalle-Aurioles, M.; Cuesta, MJ.; Saiz-Ruiz, J.; Bernardo, M.; Parellada, M.; PEPs Group.

Schizophrenia Bulletin

       

Effects of functional remediation on neurocognitively impaired bipolar patients: enhancement of verbal memory

2015

Bonnin, CM.; Reinares, M.; Martínez-Arán, A.; Balanzá-Martínez, V.; Sole, B.; Torrent, C.; Tabarés-Seisdedos, R.; García-Portilla, MP.; Ibáñez, A.; Amann, BL.; Arango, C.; Ayuso-Mateos, JL.; Crespo, JM.; González-Pinto, A.; Colom, F.; Vieta, E; CIBERSAM F.

Psychological Medicine

       

Mental health research priorities for Europe

2015

Wykes, T.; Haro, JM.; Belli, SR.; Obradors-Tarragó, C.; Arango C.; Ayuso-Mateos JL.; Bitter, I.; Brunn, M.; Chevreul, K.; Demotes-Mainard, J.; Elfeddali, I.; Evans-Lacko, S.; Fiorillo, A.; Forsman, AK.; Hazo, JB.; Kuepper, R.; Knappe, S.; Leboyer, M.; Lew.

Lancet Psychiatry

       

Services for people at high risk improve outcomes in patients with first episode psychosis

2015

Fusar-Poli, P.; Díaz-Caneja, CM.; Patel, R.; Valmaggia, L.; Byrne, M.; Garety, P.; Shetty, H.; Broadbent, M.; Stewart, R.; McGuire, P.

Acta Psychiatrica Scandinavica

       
       
       
       
       

 

The Neurobiology of Autism Spectrum disorders.

 

2014

 

Parellada, M.; Penzol, MJ.; Pina, L.; Moreno, C.; Gonzalez-Vioque, E.; Salsean, G.; Arango, C.

 

European Psychiatry.29 (2014) 11-19. (F.I.: 3.285).

 

Movie for the Assessment of Social Cognition (MASC): Spanish Validation.

 

2014

 

Lahera G, Boada L, Pousa E, Mirapeix I, Morón-Nozaleda G, Marinas L, Gisbert L, Pamiàs M, Parellada M.

 

J Autism Dev Disord. 2014 Feb 13. [Epub ahead of print].

Synaptic, transcriptional and chromatin genes disrupted in autism.

2014

De Rubeis, S.; He, X.; Goldberg, AP.; Poultney, CS.; Samocha, K.; Ercument Cicek, A.; Kou,Y.; Liu, L.; Fromer, M.; Walker, S.; Singh, T.; Klei, L.; Kosmicki, J.; Fu, SC.; Aleksic, B.; Biscaldi, M.;Bolton, PF.; Brownfeld, JM.; Cai, J.; Campbell, NG.; Carracedo, A.; Chahrour, MH.; Chiocchetti, AG.;Coon, H.; Crawford, EL.; Crooks, L.; Curran, SR.; Dawson, G.; Duketis, E.; Fernandez, BA.;Gallagher, L.; Geller, E.; Guter, SJ.; Sean Hill, R.; Ionita-Laza, I.; Jimenez Gonzalez, P.; Kilpinen, H.;Klauck, SM.; Kolevzon, A.; Lee, I.; Lei, J.; Lehtimäki, T.; Lin, CF.; Ma'ayan, A.; Marshall, CR.;McInnes, AL.; Neale, B.; Owen, MJ.; Ozaki, N.; Parellada, M.; Parr, JR.; Purcell, S.; Puura, K.;Rajagopalan, D.; Rehnström, K.; Reichenberg, A.; Sabo, A.; Sachse, M.; Sanders, SJ.; Schafer, C.;Schulte-Rüther, M.; Skuse, D.; Stevens, C.; Szatmari, P.; Tammimies, K.; Valladares, O.; Voran, A.;Wang, LS.; Weiss, LA.; Jeremy, Willsey.; Yu, TW.; Yuen, RK.; DDD Study; Homozygosity MappingCollaborative for Autism; UK10K Consortium; Autism Sequencing Consortium; Cook, EH.; Freitag,CM.; Gill, M.; Hultman, CM.; Lehner, T.; Palotie, A.; Schellenberg, GD.; Sklar, P.; State, MW.;Sutcliffe, JS.; Walsh, CA.; Scherer, SW.; Zwick, ME.; Barrett, JC.; Cutler, DJ.; Roeder, K.; Devlin, B.;Daly, MJ.; Buxbaum, JD.

Nature

 

Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: A 2-year longitudinal study

 

2014

 

Fraguas D., Del Rey-Mejías A., Moreno C., Castro-Fornieles J., Graell M4, Otero S., Gonzalez-Pinto A., Moreno D., Baeza I., Martínez-Cengotitabengoa M., Arango C., Parellada M.

 

Schizophr Res. 2014 Jan;152(1):130-8. doi: 10.1016/j.schres.2013.11.018. Epub 2013 Dec 9

 

The effects of second-generation antipsychotics on food intake, resting energy expenditure and physical activity.

 

2014

 

Cuerda C., Velasco C., Merchán-Naranjo J., García-Peris P., Arango C.

 

Eur J Clin Nutr. 2014 Feb;68(2):146-52. doi: 10.1038/ejcn.2013.253. Epub 2013 Dec 11.

 

Differential neurodevelopmental trajectories in patients with early-onset bipolar and schizophrenia disorders.

 

2014

 

Arango, C.; Fraguas, D.; Parellada, M.

Schizophrenia Bulletin. (en prensa). (F.I.: 8.486).

       

Common variant at 16p11.2 conferring risk of psychosis.

2014

Steinberg, S.; de Jong, S.; Mattheisen, M.; Costas, J.; Demontis, D.; Jamain, S.; Pietiläinen, OP.; Lin, K.; Papiol, S.; Huttenlocher, J.; Sigurdsson, E.; Vassos, E.; Giegling, I.; Breuer, R.; Fraser, G.; Walker, N.; Melle, I.; Djurovic, S.; Agartz, I.; Tuulio-Henriksson, A.; Suvisaari, J.; Lönnqvist, J.; Paunio, T.; Olsen, L.; Hansen, T.; Ingason, A.; Pirinen, M.; Strengman, E.; Hougaard, DM.; Orntoft, T.; Didriksen, M.; Hollegaard, MV.; Nordentoft, M.; Abramova, L.; Kaleda, V.; Arrojo, M.; Sanjuán, J.; Arango, C.; Etain, B.; Bellivier, F.; Méary, A.; Schürhoff, F.; Szoke, A.; Ribolsi, M.; Magni, V.; Siracusano, A.; Sperling, S.; Rossner, M.; Christiansen, C.; Kiemeney, LA.; Franke, B.; van den Berg, LH.; Veldink, J.; Curran, S.; Bolton, P.; Poot, M.; Staal, W.; Rehnstrom, K.; Kilpinen, H.; Freitag, CM.; Meyer, J.; Magnusson, P.; Saemundsen, E.; Martsenkovsky, I.; Bikshaieva, I.; Martsenkovska, I.; Vashchenko, O.; Raleva, M.; Paketchieva, K.; Stefanovski, B.; Durmishi, N.; Pejovic Milovancevic, M.; Lecic Tosevski, D.; Silagadze, T.; Naneishvili, N.; Mikeladze, N.; Surguladze, S.; Vincent, JB.; Farmer, A.; Mitchell, PB.; Wright, A.; Schofield, PR.; Fullerton, JM.; Montgomery, GW.; Martin, NG.; Rubino, IA.; van Winkel, R.; Kenis, G.; De Hert, M.; Réthelyi, JM.; Bitter, I.; Terenius, L.; Jönsson, EG.; Bakker, S.; van Os, J.; Jablensky, A.; Leboyer, M.; Bramon, E.; Powell, J.; Murray, R.; Corvin, A.; Gill, M.; Morris, D.; O'Neill, FA.; Kendler, K.; Riley, B; Wellcome Trust Case Control Consortium 2.; Craddock, N.; Owen, MJ.; O'Donovan, MC.; Thorsteinsdottir, U.; Kong, A.; Ehrenreich, H.; Carracedo, A.; Golimbet, V.; Andreassen, OA.; Børglum, AD.; Mors, O.; Mortensen, PB.; Werge, T.; Ophoff, RA.; Nöthen, MM.; Rietschel, M.; Cichon, S.; Ruggeri, M.; Tosato, S.; Palotie, A.; St Clair, D.; Rujescu, D.; Collier, DA.; Stefansson, H.; Stefansson K

Molecular Psychiatry

Intervention for Adolescents With Early Onset Psychosis and Their Families: A Randomized Controlled Trial. The PIENSA program.

2014

Ana Calvo, Miguel Moreno, Ana Ruiz-Sancho, Marta Rapado-Castro, Carmen Moreno, Teresa Sánchez-Gutiérrez, Celso Arango, María Mayoral.

Journal of the American Academic of Child and Adolescent Psychiatric

       

Schizophrenia—Time to Commit to Policy Change

2014

W. Wolfgang Fleischhacker, Celso Arango, Paul Arteel, Thomas R. E. Barnes, William Carpenter,
Ken Duckworth, Silvana Galderisi, Lisa Halpern, Martin Knapp, Stephen R. Marder, Mary Moller,
Norman Sartorius, and Peter Woodruff

Schizophrenia Bulletin vol. 40 suppl. no. 3 pp. S165–S194, 2014

       

Pro-/Anti-inflammatory Dysregulation in Patients with First Episode of Psychosis: Toward an Integrative Inflammatory Hypothesis of Schizophrenia

2014

García-Bueno, B.; Bioque M.; Mac-Dowell, KS.; Barcones, MF., Monica Martínez-Cengotitabengoa, Laura Pina-Camacho, Roberto Rodríguez-Jiménez, Pilar A. Sáiz, Carmen Castro, Amalia Lafuente, Javier Santabárbara, Ana González-Pinto, Mara Parellada, Gabriel Rubio, M.Paz Garcia-Portilla, Juan A. Micó, Miguel Bernardo, Juan C. Leza

Schizophrenia Bulletin

Basal low antioxidant capacity correlates with cognitive deficits in earlyonset psychosis. A 2-year follow-up study

2014

Mónica Martínez-Cengotitabengoa, Juan Antonio Micó, Celso Arango, Josefina Castro-Fornieles,
Montserrat Graell, Beatriz Payá, Juan Carlos Leza, Iñaki Zorrilla, Mara Parellada,
Mª. Purificación López, Inmaculada Baeza, Carmen Moreno, Marta Rapado-Castro, Ana González-Pinto

Schizophrenia Research 156 (2014) 23–29

       

Oxidative/Nitrosative Stress in Psychiatric Disorders: Are We There Yet?

2014

O'Donnell P, Do KQ, Arango C.

Schizophr Bull. 2014 Apr 8.

       

Cortical morphology of adolescents with bipolar disorder and with schizophrenia

2014

Janssen J, Alemán-Gómez Y, Schnack H, Balaban E, Pina-Camacho L, Alfaro-Almagro F, Castro-Fornieles J, Otero S, Baeza I, Moreno D, Bargalló N, Parellada M, Arango C, Desco M.

Schizophrenia Research

A longitudinal study on the relationship between duration of untreated psychosis and executive function in early-onset first-episode psychosis

2014

Fraguas D, Merchán-Naranjo J, Del Rey-Mejías A, Castro-Fornieles J, González-Pinto A, Rapado-Castro M, Pina-Camacho L, Díaz-Caneja CM, Graell M, Otero S, Baeza I, Moreno C, Martínez-Cengotitabengoa M, Rodríguez-Toscano E, Arango C, Parellada M.

Schizophrenia Research

Development of the Spanish Brief-version of the University of California Performance Skills Assessment (Sp-UPSA-Brief) in patients with schizophrenia and bipolar disorder

2014

Garcia-Portilla MP, Gomar J, Bobes-Bascaran MT, Menendez-Miranda I, Saiz PA, Muñiz J, Arango C, Patterson T, Harvey P, Bobes J, Goldberg T.

Revista de Psiquiatría y Salud Mental

       

Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations

2014

European Network of National Networks studying Gene-Environment Interactions in Schizophrenia (EU-GEI), van Os J, Rutten BP, Myin-Germeys I, Delespaul P, Viechtbauer W, van Zelst C, Bruggeman R, Reininghaus U, Morgan C, Murray RM, Di Forti M, McGuire P, Valmaggia LR, Kempton MJ, Gayer-Anderson C, Hubbard K, Beards S, Stilo SA, Onyejiaka A, Bourque F, Modinos G, Tognin S, Calem M, O'Donovan MC, Owen MJ, Holmans P, Williams N, Craddock N, Richards A, Humphreys I, Meyer-Lindenberg A, Leweke FM, Tost H, Akdeniz C, Rohleder C, Bumb JM, Schwarz E, Alptekin K, Üçok A, Saka MC, Atbaşoğlu EC, Gülöksüz S, Gumus-Akay G, Cihan B, Karadağ H, Soygür H, Cankurtaran EŞ, Ulusoy S, Akdede B, Binbay T, Ayer A, Noyan H, Karadayı G, Akturan E, Ulaş H, Arango C, Parellada M, Bernardo M, Sanjuán J, Bobes J, Arrojo M, Santos JL, Cuadrado P, Rodríguez Solano JJ, Carracedo A, García Bernardo E, Roldán L, López G, Cabrera B, Cruz S, Díaz Mesa EM, Pouso M, Jiménez E, Sánchez T, Rapado M, González E, Martínez C, Sánchez E, Olmeda MS, de Haan L, Velthorst E, van der Gaag M, Selten JP, van Dam D, van der Ven E, van der Meer F, Messchaert E, Kraan T, Burger N, Leboyer M, Szoke A, Schürhoff F, Llorca PM, Jamain S, Tortelli A, Frijda F, Vilain J, Galliot AM, Baudin G, Ferchiou A, Richard JR, Bulzacka E, Charpeaud T, Tronche AM, De Hert M, van Winkel R, Decoster J, Derom C, Thiery E, Stefanis NC, Sachs G, Aschauer H, Lasser I, Winklbaur B, Schlögelhofer M, Riecher-Rössler A, Borgwardt S, Walter A, Harrisberger F, Smieskova R, Rapp C, Ittig S, Soguel-dit-Piquard F, Studerus E, Klosterkötter J, Ruhrmann S, Paruch J, Julkowski D, Hilboll D, Sham PC, Cherny SS, Chen EY, Campbell DD, Li M, Romeo-Casabona CM, Emaldi Cirión A, Urruela Mora A, Jones P, Kirkbride J, Cannon M, Rujescu D, Tarricone I, Berardi D, Bonora E, Seri M, Marcacci T, Chiri L, Chierzi F, Storbini V, Braca M, Minenna MG, Donegani I, Fioritti A, La Barbera D, La Cascia CE, Mulè A, Sideli L, Sartorio R, Ferraro L, Tripoli G, Seminerio F, Marinaro AM, McGorry P, Nelson B, Amminger GP, Pantelis C, Menezes PR, Del-Ben CM, Gallo Tenan SH, Shuhama R, Ruggeri M, Tosato S, Lasalvia A, Bonetto C, Ira E, Nordentoft M, Krebs MO, Barrantes-Vidal N, Cristóbal P, Kwapil TR, Brietzke E, Bressan RA, Gadelha A, Maric NP, Andric S, Mihaljevic M, Mirjanic T.

Schizophrenia Bulletin

Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia

2014

Usall J, López-Carrilero R, Iniesta R, Roca M, Caballero M, Rodriguez-Jimenez R, Oliveira C, Bernardo M, Corripio I, Sindreu SD, González Piqueras JC, Felipe AE, Fernandez de Corres B, Ibáñez A, Huerta R; Abordaje Síntomas Negativos Esquizofrenia (ASINE) Group

Journal of Clinical Psychiatry

Antipsychotic Use in Children and Adolescents: A 1-Year Follow-Up Study

2014

Baeza I, de la Serna E, Calvo-Escalona R, Morer A, Merchán-Naranjo J, Tapia C, Martínez-Cantarero MC, Andrés P, Alda JA, Sánchez B, Arango C, Castro-Fornieles J.

Journal of Clinical Psychopharmacology

Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges

2014

Glennon J, Purper-Ouakil D, Bakker M, Zuddas A, Hoekstra P, Schulze U, Castro-Fornieles J, Santosh PJ, Arango C, Kölch M, Coghill D, Flamarique I, Penzol MJ, Wan M, Murray M, Wong ICK, Danckaerts M, Bonnot O, Falissard B, Masi G, Fegert JM, Vicari S, Carucci s, Dittmann RW, Buitelaar JK, and the PERS Consortium

European Child and Adolescent Psychiatry

Predictors of schizophrenia spectrum disorders in early-onset first episodes of psychosis: a support vector machine model

2014

Pina-Camacho L, Garcia-Prieto J, Parellada M, Castro-Fornieles J, Gonzalez-Pinto AM, Bombin I, Graell M, Paya B, Rapado-Castro M, Janssen J, Baeza I, Pozo FD, Desco M, Arango C

European Child and Adolescent Psychiatry

       

Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case–control sample from Spain

2014

Ivorra JL, Rivero O, Costas J, Iniesta R, Arrojo M, Ramos-Ríos R, Carracedo A, Palomo T, Rodriguez-Jimenez R, Cervilla J, Gutiérrez B, Molina E, Arango C, Álvarez M, Pascual JC, Pérez V, Saiz PA, García-Portilla MP, Bobes J, González-Pinto A, Zorrilla I, Haro JM, Bernardo M, Baca-García E, González JC, Hoenicka J, Moltó MD.

Schizophrenia Research

The affective dimension of early-onset psychosis and its relationship with suicide

2014

Sanchez-Gistau V, Baeza I, Arango C, González-Pinto A, de la Serna E, Parellada M, Graell M, Paya B, Llorente C, Castro-Fornieles J.

Journal of Child Psychology and Psychiatry

Functional remediation for patients with bipolar II disorder: Improvement of functioning and subsyndromal symptoms

2014

Solé B, Bonnin CM, Mayoral M, Amann BL, Torres I, González-Pinto A, Jimenez E, Crespo JM, Colom F, Tabarés-Seisdedos R, Reinares M, Ayuso-Mateos JL, Soria S, Garcia-Portilla MP, Ibañez A, Vieta E, Martinez-Aran A, Torrent C; the CIBERSAM Functional Remediation Group.

European Neuropsychopharmacology

More Treatment for Those Most in Need? A Foregone Conclusion?

2014

Arango C, Kahn RS

Schizophrenia Bulletin

       

Second-Generation Antipsychotic Use in Children and Adolescents: A Six-Month Prospective Cohort Study in Drug-Naïve Patients

2014

Arango, C.; Giráldez, M.; Merchán-Naranjo, J.; Baeza, I.; Castro-Fornieles, J.; Alda, JA.; Martínez-Cantarero, C.; Moreno, C; de Andrés, P; Cuerda, C; de la Serna, E; Correll, C.; Fraguas, D.;

Journal of the American Academy of Child and Adolescent Psychiatry

       

Present and future of developmental neuropsychopharmacology

2014

Arango C

European Neuropsychopharmacology

       

Bipolar I and II versus unipolar depression: Clinical differences and impulsivity/aggression traits

2014

Dervic, K.; Garcia-Amador, M.; Sudol, K.; Freed, P.; Brent, D.; Mann, JJ.; Harkavy-Friedman,

European Psychiatry

       

Schizophrenia International Research Society Conference, 5-9 April 2014, Florence, Italy: A summary of topics and trends

 

Abayomi, O.; Amato, D.; Bailey, C.; Bitanihirwe, B.; Bowen, L.; Burshtein, S.; Cullen, A.; Fusté, M.; Herrmann, AP.; Khodaie, B.; Kilian, S.; Lang, QA.; Manning, EE.; Massuda, R.; Nurjono, M.; Sadiq, S.; Sanchez-Gutierrez, T.; Sheinbaum, T.; Shivakumar, V.; Simon, N.; Spiteri-Staines, A.; Sirijit, S.; Toftdahl, NG.; Wadehra, S.; Wang, Y.; Wigton, R.; Wright, S.; Yagoda, S.; Zaytseva, Y.; O'Shea, A.; DeLisi, LE.

Schizophrenia Research

Tobacco Use in Bipolar Disorder

2014

Thomson, D.; Berk, M.; Dodd, S.; Rapado-Castro, M.; Quirk, SE.; Ellegaard, PK.; Berk, L.; Dean, OM.

Clinical Psychopharmacology and Neuroscience

       

A Pharmacogenetic study of Second-generation antipsychotic Long-tem treatment Metabolic side effects (The SLiM study): rationale, objectives, and design

 

Pina-Camacho, L.; Díaz-Caneja, CM.; Saiz, PA.; Bobes, J.; Corripio, I.; Grasa, E.; Rodriguez-Jimenez, R.; Fernández, M.; Sanjuán, J.; García-López, A.; Tapia-Casellas, C.; Álvarez-Blázquez, M.;Fraguas, D.; Mitjans, M.; Arias, B.; Arango, C

Revista de Psiquiatría y Salud Mental

       

 

ROAMER: roadmap for mental health research in Europe

 

2014

 

Haro JM, Ayuso-Mateos JL, Bitter I, Demotes-Mainard J, Leboyer M, Lewis SW, Linszen D, Maj M, McDaid D, Meyer-Lindenberg A, Robbins TW, Schumann G, Thornicroft G, Van Der Feltz-Cornelis C, Van Os J, Wahlbeck K, Wittchen HU, Wykes T, Arango C, Bickenbach J, Brunn M, Cammarata P, Chevreul K, Evans-Lacko S, Finocchiaro C, Fiorillo A, Forsman AK, Hazo JB, Knappe S, Kuepper R, Luciano M, Miret M, Obradors-Tarragó C, Pagano G, Papp S, Walker-Tilley T.

 

Int J Methods Psychiatr Res. 2014 Jan;23 Suppl 1:1-14. doi: 10.1002/mpr.1406.

 

White matter microstructure correlates of mathematical giftedness and intelligence quotient

 

2014

 

Navas-Sánchez, FJ.; Alemán-Gómez, Y.; Sánchez-Gonzalez, J.; Guzmán-De-Villoria, JA.; Franco, C.; Robles, O.; Arango, C.; Desco, M.

 

Human Brain Mapping

       

Verbal memory as a mediator in the relationship between subthreshold depressive symptoms and functional outcome in bipolar disorder

2014

Bonnín Cdel M, González-Pinto A, Solé B, Reinares M, González-Ortega I, Alberich S, Crespo JM, Salamero M, Vieta E, Martínez-Arán A, Torrent C

CIBERSAM Functional Remediation Group. J Affect Disord. 2014 May;160:50-4. doi: 10.1016/j.jad.2014.02.034. Epub 2014 Mar 11.

       

Polypharmacy with antidepressants in children and adolescents

2014

Díaz-Caneja CM, Espliego A, Parellada M, Arango C, Moreno C.

Int J Neuropsychopharmacol. 2014 17(7):1063-82.

       

Practitioner Review: Long-term pharmacological treatment of pediatric bipolar disorder

2014

Díaz-Caneja CM, Moreno C, Llorente C, Espliego A, Arango C, Moreno D.

Journal of Child Psychology and Psychiatry

 

Structural magnetic resonance imaging data do not help support DSM-5 autism spectrum disorder category.

 

2013

 

Laura Pina-Camacho, Sonia Villero, Leticia Boada, David Fraguas, Joost Janssen, María Mayoral, Cloe Llorente, Celso Arango, Mara Parellada.

 

Research in Autism Spectrum Disorders

 

Specialty Care Programme for autism spectrum disorders in an urban population: A case-management model for health care delivery in an ASD population.

 

2013

 

Parellada, M.; Boada, L.; Moreno, C.; Llorente, C.; J. Romo, C. Muela, C.Arango.

 

European Psychiatry.

 

Psychopathology in Children and Adolescents with ASD Without Mental Retardation.

 

2013

 

Caamaño, M.; Boada L.; Merchán-Naranjo, J.; Moreno, C. Cloe Llorente; Dolores Moreno; Celso Arango; Mara Parellada.

 

Journal of Autism and Developmental Disorders.

 

Attitude and risk of substance use in adolescents diagnosed with Asperger syndrome.

 

2013

 

Ramos, M.; Boada, L.; Moreno, C.; Llorente, C.; Romo, J.; Parellada, M.

 

Drug and alcohol dependence. 2013 Dec 1;133(2):535-40 .(F.I.: 3.141).

       

 

Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis (PEPs).

 

2013

 

Bernardo, M.; Bioque, M.; Parellada, M.; Saiz Ruiz, J.; Manuel J. Cuesta; Adríán Llerena; Julio Sanjuán; Josefina Castro- Forniels; Celso Arango; Bibiana Cabrera; PEPs GROUP.

 

Revista de Psiquiatría y Salud Mental

 

Premorbid impairments in early-onset psychosis: Differences between patients with schizophrenia and bipolar disorder.

 

2013

 

Payá, B.; Rodríguez-Sánchez, JM.; Otero, S.; Muñoz, P., Josefina Castro-Fornieles, Mara Parellada, Ana González-Pinto, Cesar Soutullo, Inmaculada Baeza, Marta Rapado-Castro, Margarita Sáenz-herrero, Dolores Moreno, Celso Arango.

 

Schizophrenia Research.

 

Evidence for the early clinical relevance of hallucinatory-delusional states in the general population.

 

2013

 

Nuevo, R.; Van Os, J.; Arango, C.; Chatterji, S., J.L. Ayuso- Mateos.

 

Acta Psychiatrica Scandinavica.

       

Cognition in schizophrenia: Summary Nice Consultation Meeting 2012

2013

Nutt, D.; Gispen-de Wied, CC.; Arango, C.; Keefe, RS, Rafael Penades, Declan G. Murphy, Trevor W Robbins, Barbara j Sahakian

European Neuropsychopharmacology

Twenty-Four Months of Antipsychotic Treatment in Children and Adolescents With First Psychotic Episode - Discontinuation and Tolerability

2013

Ana Noguera, Patricia Ballesta, Immaculada Baeza, Celso Arango, Elena de la Serna, Ana González-Pinto, Mara Parellada, Montserrat Graell, Carmen Moreno, Soraya Otero, Josefina Castro-Fornieles

Journal of Clinical Psychopharmacology

       

 

Psychotic symptoms are associated with physical health problems independently of a mental disorder diagnosis: results from the WHO World Health Survey.

 

2013

 

Carmen Moreno, Roberto Nuevo, Somnath Chatterji, Emese Verdes, Celso Arango, José Luis Ayuso-Mateos.

 

World Psychiatry.

 

A simulation model to estimate 10-year risk of coronary heart disease events in patients with schizophrenia spectrum disorders treated with second-generation antipsychotic drugs.

 

2013

 

Darbà, J.; Kaskens, L.; Aranda, P.; Arango, C.; Bobes, J.; Carmena, R.; Rejas, J.

 

Annals of Clinical Psychiatry, 5(1):17-26, 2013. (F.I.: 1.490).

 

PIENSA: The development of an Early Intervention Program for Adolescents with Early Onset Psychosis and their families.

 

2013

 

Ruiz Sancho, A.; Calvo Calvo, AB.; Rapado Castro, M.; Moreno Iñiguez, M.; Moreno, C.; Sanchez Gutiérrez, T.; Tapia Casellas, C.; Chiclana Actis, G.; Rodriguez La Torre, P.; Fernández, P.; Arango López, C. Mayoral Aragón, M.

 

Adolescent Psychiatry.

 

Peripheral endocannabinoid system dysregulation in first-episode psychosis.

 

2013

 

Miquel Bioque, Borja Garcı´a-Bueno, Karina S Mac-Dowell, Ana Meseguer, Pilar A. Saiz, Mara Parellada, Ana González-Pinto, Roberto Rodrígue-Jiménez, Antonio Lobo, Juan C.Leza, Miguel Bernardo, CIBERSAM.

 

Neuropshychopharmacology.

 

Neuropsychological evidence for abnormal neurodevelopment associated with early onset psychoses.

 

2013

 

Bombin, I., Mayoral, M., Castro-Fornieles, J., Gonzalez-Pinto, A., de la Serna, E., Rapado-Castro, M., Barbeito, S., Parellada, M., Baeza, I., Graell, M., Payá, B., Arango, C.

 

Psychological Medicine, 43(4):757-68, 2013. (F.I.: 5.587).

 

Validation of a European Spanish-version of the University of California Performance Skills Assessment (Sp-UPSA) in patients with schizophrenia and bipolar disorder.

 

2013

 

Garcia-Portilla, MP.; Gomar, JJ.; Bobes-Bascaran, MT.; Menendez-Miranda, I.; Saiz, P.; Muñiz, J.; Arango, C.; Patterson, T.; Harvey, P.; Bobes, J.; Goldberg, T.

 

Schizophrenia Research, 150(2-3): 421-426, 2013. (F.I.: 4.590).

 

Social cognition in schizophrenia: from evidence to treatment.

 

2013

 

Parellada, M.

 

American Journal of Psychiatry, 170(10):1216, 2013. (F.I.: 14.721).

 

Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia.

 

2013

 

Marder, SR.; Alphs, L.; Anghelescu, IG.; Arango, C.; Barnes, TR.; Caers, I.; Daniel, DG.; Duneyevich, E.; Fleischhacker, WW.; Garibaldi, G.; Green, MF.; Harvey, PD.; Kahn, RS.; Kane, JM.; Keefe, RS.; Kinon, B.; Leucht, S.; Lindenmayer, JP.; Malhotra, AK.; Stauffer, V.; Umbricht, D.; Wesnes, K.; Kapur, S.; Rabinowitz, J.

 

Schizophrenia Research. 2013 Nov;150(2-3):328-33 (F.I.: 4.590).

 

Parents with bipolar disorder: Are disease characteristics good predictors of psychopathology in offspring?.

 

2013

 

Garcia-Amador, M.; de la Serna, E.; Vila, M.; Romero, S.; Valenti, M.; Sanchez-Gistau, V.; Benabarre, A.; Vieta E.; Castro-Fornieles, J.

 

European Psychiatry, 28(4):240-6, 2013. (F.I.: 3.285).

 

Predictors of suicide attempt in early-onset, first-episode psychoses: a longitudinal 24-month follow-up study.

 

2013

 

Sanchez-Gistau, V.; Baeza, I.; Arango, C.; González-Pinto, A.; de la Serna, E.; Parellada, M.; Graell, M.; Paya, B.; Llorente, C.; Castro-Fornieles, J.

 

Journal of Clinical Psychiatry74(1):59-66, (F.I.: 5.812).

 

Neuropsychological correlates of P50 sensory gating in patients with schizophrenia.

 

2013

 

Sánchez-Morla, EM.; Santos, JL.; Aparicio, A.; García-Jiménez, MA.; Soria, C.; Arango, C.

 

Schizophrenia Research. 143(1):102-6, 2013. (F.I.: 4.590).

 

The bipolar-depressive continuum in the National Epidemiologic Survey on Alcohol and Related Conditions.

 

2013

 

Moreno, C.; Hasin, DS.; Arango, C.; Oquendo, MA.; Vieta, E.; Liu, S.; Grant, BF.; Blanco, C.

 

Bipolar Disorders, 15(1):112-113, 2013. (F.I.: 4.621).

 

Cognitive reserve as a predictor of two year neuropsychological performance in early onset first-episode schizophrenia.

 

2013

 

de la Serna, E.; Andrés-Perpiñá, S.; Puig, O.; Baeza, I.; Bombin, I.; Bartrés-Faz, D.; Arango, C.; Gonzalez-Pinto, A.; Parellada, M.; Mayoral, M.; Graell, M.; Otero, S.; Guardia, J.; Castro-Fornieles, J.

 

Schizophrenia Research. 143(1):125-31, 2013. (F.I.: 4.590).

 

Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation.

 

2013

 

Mac-Dowell, KS.; García-Bueno, B.; Madrigal, JLM.; Parellada, M., C. Arango, J.A. Micó, J.C. Leza.

 

International Journal of Neuropsychopharmacology.

 

Borderline Intellectual Functioning: Consensus and good practice guidelines.

 

2013

 

Salvador-Carulla, L.; García-Gutiérrez, JC.; Ruiz Gutiérrez-Colosía, M.; Artigas-Pallarès, J.; García Ibáñez, J; González Pérez, J; Nadal Pla, M.; Aguilera Inés, F.; Isus, S.; Cereza, J.M.; Poole, M.; Portero Lazcano, G.; Monzón, P.; Leiva, M.; Parellada, M.; García Nonell, K.; Martínez i Hernández, A.; Rigau, E.; Martínez-Leal, R.

 

Revista de Psiquiatría y Salud Mental.

 

Why psychogeriatrics starts right after adolescence.

 

2013

 

Mara Parellada.

 

Eur Child Adolesc Psychiatry.

 

Child neuropsychopharmacology: good news… the glass is half full.

 

2013

 

Arango, C.

 

World Psychiatry, 12(2):128-9, 2013. (F.I.: 8.974).

 

Empirical redefinition of delusional disorder and its phenomenology: the DELIREMP study.

 

2013

 

de Portugal, E.; González, N.; del Amo, V.; Haro, JM.; Díaz-Caneja, CM.; Luna del Castillo, Jde D.; Cervilla, JA.

 

Comprehensive psychiatry, 54(3):243-55, 2013. (F.I.: 2.376).

 

Efficacy of Functional Remediation in Bipolar Disorder: A Multicentre, Randomized- Controlled Study.

 

2013

 

Torrent, C.; del Mar Bonnin, C.: Martinez-Arán, A.; del Valle, J.; Amann, B.; González-Pinto, A.; Crespo, JM; Ibañez, A.; Garcia-Portilla, MP.; Tabarés-Seisdedos, R.; Arango, C.; Colom, F.; Solé B.; Pacchiarotti, I.; Rosa, AR.; Ayuso-Mateos, JL; Anaya, C; Fernández, P.; Landín-Romero, R; Alonso, S.: Ortiz-Gil, A.; Segura, B.; Barbeito, S.; Vega, S.; Fernández, S.; Ugarte, A.; Subirà, A; Cerrillo, E.; Custal, N.; Menchón, JM.; Saiz-Ruiz, J.; Rodao, MJ.; Isella, S.; Alegría, A.; Al-Halabi, S.; Bobes, J.; Galván, G.; Saiz, PA.; Balanzá-Martínez, V.; Selva, G.; Fuentes-Durá, I.; Correa, P.; Mayoral, M.; Chiclana, G., Merchan-Naranjo, J., Rapado-Castro, M.; Salamero, M.; Vieta, E.

 

American Journal of Psychiatry, 170(8):852-9, 2013. (F.I.: 14.721).

 

To treat or not to treat? and How to treat? Two questions whose answers are far removed from evidence informed practice in child psychiatry.

 

2013

 

Arango, C.

 

European Child and Adolescent Psychiatry, 22(9):521-2, 2013. (F.I.: 3.699).

 

The Human Cerebral Cortex Flattens during Adolescence.

 

2013

 

Alemán-Gómez, Y.; Janssen, J.; Schnack, H.; Balaban, E.; Pina-Camacho, L.; Alfaro-Almagro, F.; Castro-Fornieles, J.; Otero, S.; Baeza, I.; Moreno, D.; Bargalló, N.; Parellada, M.; Arango, C.; Desco, M.

 

Journal of Neuroscience, 33(38):15004-15010, 2013. (F.I.: 6.908).

 

Deficits in executive and memory processes in delusional disorder: a case-control study.

 

2013

 

Ibanez-Casas, I.; De Portugal, E.; Gonzalez, N.; McKenney, KA.; Haro, JM.; Usall, J.; Perez-Garcia, M.; Cervilla, JA.

 

Plos One, 8(7):e67341, 2013. (F.I.: 3.730).

 

Prevalence of premorbid personality disorder and its clinical correlates in patients with delusional disorder.

 

2013

 

de Portugal, E.; Díaz-Caneja, CM.; González-Molinier, M.; de Castro, MJ.; Del Amo, V.; Arango, C.; Cervilla, JA.

 

Psychiatry Research.

 

Impact of caregiving experience on mental health among caregivers: a comparison of eating disorder patients with purging and non-purging behaviors

 

2013

 

Sepulveda, AR.; Anastasiadou, D.; Pellegrin, Y.; Andrés, P.; Graell, M.; Carrobles, JA.; Morandé, G.

 

Eating and weight disorders.

 

White matter microstructure correlates of mathematical giftedness and intelligence quotient.

 

2013

 

Navas-Sánchez, FJ.; Alemán-Gómez, Y.; Sánchez-Gonzalez, J.; Guzmán-De-Villoria, JA.; Franco, C.; Robles, O.; Arango, C.; Desco, M.

 

Human Brain Mapping.

 

The bipolar-depressive continuum in the National Epidemiologic Survey on Alcohol and Related Conditions.

 

2013

 

Moreno, C.; Hasin, DS.; Arango, C.; Oquendo, MA.; Vieta, E.; Liu, S.; Grant, BF.; Blanco, C.

 

Bipolar Disorders, 15(1):112-113, 2013. (F.I.: 4.621).

 

Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges.

 

2013

 

Glennon, J.; Purper-Ouakil, D.; Bakker, M.; Zuddas, A.; Hoekstra, P.; Schulze, U.; Castro-Fornieles, J.; Santosh, PJ.; Arango, C.; Kölch, M.; Coghill, D.; Flamarique, I.; Penzol, MJ.; Wan, M.; Murray, M.; Wong, ICK.; Danckaerts, M.; Bonnot, O.; Falissard, B.; Masi, G.; Fegert, JM.; Vicari, S.; Carucci, s.; Dittmann, RW.; Buitelaar, JK.; and the PERS Consortium.

 

European Child and Adolescent Psychiatry. (en prensa). (F.I.: 3.699).

Pharmacological approaches to treating negative symptoms: A review of clinical trials.

2013

Arango, C.; Garibaldi, G.; Marder, SR.

Schizophrenia Research. 2013 Nov;150(2-3):346-52 (F.I.: 4.590).

       

The Spanish validation of an Eating Disorders Symptom Impact Scale (EDSIS) among caregivers.

2013

Carral-Fernández, L.; Sepulveda, AR.; Gómez Del Barrio, A.; Graell, M.; Treasure, J.

Psychiatry Research, 209(3):626-31, 2013. (F.I.: 2.456).